help button home button Endocrine Society JCEM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH

This version published online on July 25, 2006
Journal of Clinical Endocrinology & Metabolism, doi:10.1210/jc.2005-2411
A more recent version of this article appeared on October 1, 2006
This Article
Right arrow Author Manuscript (PDF)
Right arrow All Versions of this Article:
91/10/4099    most recent
Author Manuscript (PDF)
Right arrow Submit a related Letter to the Editor
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Berk, E. S.
Right arrow Articles by Albu, J. B.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Berk, E. S.
Right arrow Articles by Albu, J. B.
Right arrowPubmed/NCBI databases
*Compound via MeSH
*Substance via MeSH
Hazardous Substances DB
*EPINEPHRINE

Submitted on November 4, 2005
Accepted on July 13, 2006

Metabolic Inflexibility in Substrate Utilization Is Present in African-American but Not Caucasian Healthy, Pre-Menopausal, Non-Diabetic Women

Evan S. Berk, Albert J. Kovera, Carol N Boozer, F. Xavier Pi-Sunyer, and Jeanine B. Albu*

New York Obesity Research Center, St. Luke's-Roosevelt Hospital Center, Columbia University, New York, New York

* To whom correspondence should be addressed. E-mail: jba1{at}columbia.edu.

Context: There is an increased prevalence of obesity and insulin resistance in African American compared with Caucasian females. Metabolic inflexibility (MI) is the inability to switch the utilization of lipids and carbohydrates in the peripheral tissue (i.e. muscle) based upon substrate availability.

Objective: We examined if MI exists in African American females.

Main Outcome Measures and Design: We measured substrate utilization differences during eucaloric, macronutrient-manipulated diets [high fat (HF, 50% Fat, 35% CHO, 15% Protein) vs. low fat (LF, 30% Fat, 55% CHO, 15% Protein)] between Caucasian and African American women. We also compared differences in substrate utilization in response to insulin infusion during 2-step pancreatic-euglycemic clamps and epinephrine infusion during lipolysis studies. In each study, similar groups of Caucasian and African American women were compared.

Results: Caucasians had significantly higher fat oxidation (FO) (P = 0.01) and lower carbohydrate oxidation (CO) (P < 0.01) during the HF vs. LF diet while no significant differences were observed in African Americans. The African American women also failed to significantly suppress FO during the second step of the pancreatic-euglycemic clamp despite a doubling of their fasting plasma insulin and failed to increase their FO or decrease their CO in response to epinephrine infusion as much as Caucasian women did. The response of free fatty acid turnover rates to insulin and epinephrine stimulation was similar between races.

Conclusion: The impaired substrate utilization observed in African American women during these three studies demonstrates the existence of MI and may contribute to their greater prevalence of obesity and insulin resistance.


Key words: Metabolic Inflexibility • Insulin Resistance • Race







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 2006 by The Endocrine Society